Regional Variation across Canadian Centers in Radioiodine Administration for Thyroid Remnant Ablation in Well-Differentiated Thyroid Cancer Diagnosed in 2000–2010
Table 6
Total Number of Patients by stage and per center receiving RAI.
Center
TNM stage
Overall by center
T1
T2
T3
T4
N1a/N1b
N0/Nx
N1a/N1b
N0/Nx
N1a/N1b
N0/Nx
N1a/N1b
N0/Nx
London
81 (96%)
325 (66%)
45 (94%)
288 (96%)
134 (99%)
171 (97%)
16 (100%)
8 (89%)
1068 (84%)
Halifax
16 (76%)
86 (60%)
3 (100%)
25 (81%)
4 (57%)
12 (71%)
1 (100%)
N/A
147 (66%)
Winnipeg
29 (52%)
55 (15%)
33 (73%)
89 (40%)
57 (71%)
74 (54%)
25 (93%)
11 (92%)
373 (40%)
Toronto
14 (74%)
80 (48%)
6 (86%)
79 (77%)
6 (100%)
44 (90%)
2 (100%)
N/A
231 (65%)
St. John’s
10 (91%)
43 (83%)
2 (100%)
31 (97%)
6 (100%)
44 (96%)
2 (100%)
1 (100%)
139 (91%)
Hamilton
11 (92%)
9 (23%)
9 (100%)
5 (33%)
9 (100%)
8 (62%)
5 (83%)
1 (100%)
57 (54%)
Fredericton
2 (50%)
8 (53%)
1 (100%)
8 (73%)
N/A
6 (86%)
N/A
N/A
25 (66%)
Overall by Stage
79%
86%
74%
89%
80%
94%
91%
66%
There were no major differences between centers. compared to N1a/N1b.
